Baird Capital has announced it has closed its first global fund with a total of approximately $310 million.
The fund invests in lower middle-market companies in healthcare and other sectors in the United States, United Kingdom and Asia.
Baird Capital, based in Chicago, is the direct investment arm of Robert W. Baird & Co. It makes private equity, venture capital and growth equity investments in healthcare and other targeted sectors.
Healthcare companies in Baird’s current portfolio include Alpha Source, a provider of solutions for medical equipment maintenance and service, medical device battery manufacturing and medical equipment parts distribution, and New Vitality, a direct marketer of supplements and personal care products.